Method for Differentiating Sepsis and Systemic Inflammatory Response Syndrome (SIRS)
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 17, 2015
app pub date -
Jan 28, 2014
filing date -
Jan 28, 2013
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A method of characterizing sepsis in a subject involves determining an amount in a biological sample from the subject of each biomarker in a biomarker panel including at least two biomarkers; and calculating a risk index or sepsis probability score using the amounts of biomarkers in the biomarker panel. Exemplary biomarker panels include TNF-alpha, interleukin-6, interleukin-10, lipopolysaccharide binding protein, and C-reactive protein; IL-1beta, procalcitonin, absolute neutrophil count, and immature granulocyte count; and Interleukin-8, GM-CSF, MCP1, and INF-gamma. The method can further involve determining one or more clinical parameters about the subject, and calculating the risk index using the amounts of the biomarkers in the biomarker panel and the clinical parameters.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully